ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för palonosetron. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

14 träffar

Bibliografisk träff 2014-12-23

Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-day granisetron for CINV in a randomized, single-blinded crossover study.

Kimura H, Yamamoto N, Shirai T, Nishida H, Hayashi K, Tanzawa Y, Takeuchi A, Igarashi K, Inatani H, Shimozaki S, Kato T, Aoki Y, Higuchi T, Tsuchiya H.

Cancer Med · research-article; randomized controlled trial; journal article · DOI 10.1002/cam4.373

Bibliografisk träff 2014-12-01

Evaluation of an every-other-day palonosetron schedule to control emesis in multiple-day high-dose chemotherapy.

Mirabile A, Celio L, Magni M, Bonizzoni E, Gianni AM, Di Nicola M.

Future Oncol · clinical trial; journal article · DOI 10.2217/fon.14.132

Bibliografisk träff 2014-10-31

Review of oral fixed-dose combination netupitant and palonosetron (NEPA) for the treatment of chemotherapy-induced nausea and vomiting.

Lorusso V, Karthaus M, Aapro M.

Future Oncol · research support, non-u.s. gov't; review; journal article · DOI 10.2217/fon.14.260

Bibliografisk träff 2014-10-24

Comparison between the antiemetic effects of palonosetron and granisetron in breast cancer patients treated with anthracycline-based regimens.

Ohzawa H, Miki A, Hozumi Y, Miyazaki C, Sagara Y, Tanaka Y, Shiba S, Joutoku H, Sakuragi M, Takehara M, Sakuma Y, Nishimura W, Fujii H, Yasuda Y.

Oncol Lett · research-article; journal article · DOI 10.3892/ol.2014.2640

Bibliografisk träff 2014-09-02

Comparison of an extended-release formulation of granisetron (APF530) versus palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately or highly emetogenic chemotherapy: results of a prospective, randomized, double-blind, noninferiority phase 3 trial.

Raftopoulos H, Cooper W, O'Boyle E, Gabrail N, Boccia R, Gralla RJ.

Support Care Cancer · clinical trial, phase iii; research support, non-u.s. gov't; research-article; multicenter study; randomized controlled trial; journal article · DOI 10.1007/s00520-014-2400-3

Bibliografisk träff 2014-07-27

Usefulness of antiemetic therapy with aprepitant, palonosetron, and dexamethasone for lung cancer patients on cisplatin-based or carboplatin-based chemotherapy.

Kitazaki T, Fukuda Y, Fukahori S, Oyanagi K, Soda H, Nakamura Y, Kohno S.

Support Care Cancer · clinical trial; journal article · DOI 10.1007/s00520-014-2339-4

Bibliografisk träff 2014-07-19

A prospective, randomized, double-blind, multicenter trial to evaluate the therapeutic efficacy and safety of palonosetron in the treatment of postoperative nausea and vomiting over a 72-h period.

Hahm TS, Hwang JW, Kim WH, Oh EJ, Kim DK, Choi WJ, Kim YH, Ryu JH, Yoo BH, Yon JH.

J Anesth · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1007/s00540-014-1884-9

Bibliografisk träff 2014-03-07

Palonosetron versus first-generation 5-hydroxytryptamine type 3 receptor antagonists for emesis prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation.

Chou CW, Chen YK, Yu YB, Chang KH, Hwang WL, Teng CL.

Ann Hematol · comparative study; journal article · DOI 10.1007/s00277-014-2038-8

Bibliografisk träff 2014-03-04

Efficacy and safety of palonosetron for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis of randomized controlled trials.

Popovic M, Warr DG, Deangelis C, Tsao M, Chan KK, Poon M, Yip C, Pulenzas N, Lam H, Zhang L, Chow E.

Support Care Cancer · meta-analysis; research support, non-u.s. gov't; systematic review; journal article · DOI 10.1007/s00520-014-2175-6

Bibliografisk träff 2014-01-01

Phase II study on EANI combined with hydrochloride palonosetron for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy.

Xiao Y, Liu J, Liu YC, Huang XE, Guo JX, Wei W.

Asian Pac J Cancer Prev · clinical trial, phase ii; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.7314/apjcp.2014.15.9.3951

Bibliografisk träff 2013-11-26

Comparison of palonosetron with palonosetron-dexamethasone combination for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy.

Bala I, Bharti N, Murugesan S, Gupta R.

Minerva Anestesiol · comparative study; randomized controlled trial; journal article

Bibliografisk träff 2013-10-22

Efficacy of palonosetron for the prevention of postoperative nausea and vomiting: a randomized, double-blinded, placebo-controlled trial.

Chun HR, Jeon IS, Park SY, Lee SJ, Kang SH, Kim SI.

Br J Anaesth · randomized controlled trial; journal article · DOI 10.1093/bja/aet340

Bibliografisk träff 2013-10-14

Effect of palonosetron on the QTc interval in patients undergoing sevoflurane anaesthesia.

Kim HJ, Lee HC, Jung YS, Lee J, Min JJ, Hong DM, Choi EK, Oh S, Jeon Y.

Br J Anaesth · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1093/bja/aet335

Bibliografisk träff 2013-05-08

A combination of aprepitant, palonosetron, and dexamethasone prevents emesis associated with anthracycline-containing regimens for patients with breast cancer. A retrospective study.

Nakayama Y, Ito Y, Tanabe M, Takahashi S, Hatake K.

Breast Cancer · clinical trial; journal article · DOI 10.1007/s12282-013-0472-4